Q&M subsidiary wins tender to operate joint testing and vaccination centre

MEDICAL technology company Acumen Diagnostics announced on Tuesday (Oct 11) that it has won the Ministry of Health’s (MOH) tender to operate one of the sites allocated for Joint Testing and Vaccination Centres (JTVCs).

The company, which is 51 per cent owned by Q&M Dental Group (Singapore) and 49 per cent owned by Aoxin Q&M Dental Group, bagged a 15-month contract to operate the JTVC from Oct 1, 2022 to Dec 31, 2023.

Actual operations will start from Nov 21, with the contract estimated to be worth at least S$3.6 million, the company said.

On Tuesday, MOH announced that the Moderna/Spikevax bivalent vaccine would be available from this Friday, three days earlier than previously announced.

Those who have yet to achieve maximum protection, as well as those aged 50 years and above who received their last dose more than five months ago, may visit one of nine JTVCs to get their dose.

Shares of Q&M Dental ended flat at S$0.33 on Tuesday, before the announcement.